Delbanco E H, Bolt H M, Huber W W, Beken S, Geller F, Philippou S, Brands F H, Brüning T, Thier R
Institut für Arbeitsphysiologie (IfADo) an der Universität Dortmund, Germany.
Arch Toxicol. 2001 Jan;74(11):688-94. doi: 10.1007/s002040000184.
In general, the biological activation of nephrocarcinogenic chlorinated hydrocarbons proceeds via conjugation with glutathione. It has mostly been assumed that the main site of initial conjugation is the liver, followed by a mandatory transfer of intermediates to the kidney. It was therefore of interest to study the enzyme activities of subgroups of glutathione transferases (GSTs) in renal cancers and the surrounding normal renal tissues of the same individuals (n = 21). For genotyping the individuals with respect to known polymorphic GST isozymes the following substrates with differential specificity were used: 1-chloro-2,4-dinitrobenzene for overall GST activity (except GST theta); 7-chloro-4-nitrobenzo-2-oxa- 1,3-diazole for GST alpha; 1,2-dichloro-4-nitro-benzene for GST mu; ethacrynic acid and 4-vinylpyridine for GST pi; and methyl chloride for GST theta. In general, the normal tissues were able to metabolize the test substrates. A general decrease in individual GST enzyme activities was apparent in the course of cancerization, and in some (exceptional) cases individual activities, expressed in the normal renal tissue, were lost in the tumour tissue. The GST enzyme activities in tumours were independent of tumour stage, or the age and gender of the patients. There was little influence of known polymorphisms of GSTM1, GSTM3 and GSTP1 upon the activities towards the test substrates, whereas the influence of GSTT1 polymorphism on the activity towads methyl chloride was straightforward. In general, the present findings support the concept that the initial GST-dependent bioactivation step of nephrocarcinogenic chlorinated hydrocarbons may take place in the kidney itself. This should be a consideration in toxicokinetic modelling.
一般来说,肾致癌性氯代烃的生物活化是通过与谷胱甘肽结合进行的。大多数学者认为,初始结合的主要部位是肝脏,随后中间体必须转移至肾脏。因此,研究21例个体的肾癌组织及其周围正常肾组织中谷胱甘肽转移酶(GSTs)亚组的酶活性很有意义。为了对个体已知的多态性GST同工酶进行基因分型,使用了以下具有不同特异性的底物:1-氯-2,4-二硝基苯用于检测总体GST活性(GST θ除外);7-氯-4-硝基苯并-2-恶唑-1,3-二氮杂茂用于检测GST α;1,2-二氯-4-硝基苯用于检测GST μ;依他尼酸和4-乙烯基吡啶用于检测GST π;氯甲烷用于检测GST θ。一般来说,正常组织能够代谢测试底物。在癌变过程中,个体GST酶活性普遍下降,在某些(特殊)情况下,正常肾组织中表达的个体活性在肿瘤组织中丧失。肿瘤中的GST酶活性与肿瘤分期、患者年龄和性别无关。已知的GSTM1、GSTM3和GSTP1多态性对测试底物活性的影响很小,而GSTT1多态性对氯甲烷活性的影响则很直接。总的来说,目前的研究结果支持这样一种观点,即肾致癌性氯代烃最初依赖GST的生物活化步骤可能发生在肾脏本身。这在毒代动力学建模中应予以考虑。